海南海藥(000566.SZ):擬對江蘇普健實施增資 構建鹽城醫藥化工全產業鏈平台
格隆匯3月23日丨海南海藥(000566.SZ)公佈,本着充分發揮各方資源優勢的原則,為構建鹽城醫藥化工全產業鏈平台,公司和海南海藥控股公司重慶天地藥業有限責任公司(“天地藥業”)擬對江蘇普健藥業有限公司(“江蘇普健”)實施增資:(1)海南海藥擬以子公司鹽城開元醫藥化工有限公司(“鹽城開元”)5312.02萬元債權增資江蘇普健;(2)海南海藥通過現金1億元增資江蘇普健;(3)天地藥業以鹽城開元淨資產評估值12973.7萬元增資江蘇普健。
同時,江蘇漢闊貿易有限公司(重組前江蘇普健股東,“漢闊貿易”)對江蘇普健進行增資:(1)漢闊貿易以所持江蘇漢闊生物有限公司(“江蘇漢闊”)淨資產評估值6731.89萬元增資江蘇普健。(2)漢闊貿易以所持江蘇漢闊4000萬元債權增資江蘇普健;(3)漢闊貿易以現金4920.27萬元增資江蘇普健。鹽城市瑞康醫藥化工有限公司(重組前江蘇普健股東,“鹽城瑞康”)以所持江蘇普健淨資產評估值471.02萬元(按實際出資額計算)繼續作為江蘇普健股東。
此次交易完成後,海南海藥和天地藥業共計持有江蘇普健60%股權;漢闊貿易與鹽城瑞康合計持有江蘇普健35%股權;江蘇普健預留5.00%增資認繳權,作為高管團隊的股權激勵,登記在漢闊貿易名下。
本着充分發揮各方資源優勢的原則,擬以江蘇普健為平台構建鹽城醫藥化工全產業鏈平台,與江蘇省鹽城市濱海縣政府一起整合濱海醫藥產業園優勢企業,強強聯合,組建具有國際競爭力的生物醫藥產業集團,打造鹽城市乃至江蘇省有影響力的“中間體-原料藥-製劑”全產業示範基地。
此次合作有利於整合各方資源、技術、人才等方面優勢,推進各方在醫藥產品與服務領域開展廣泛合作,為公司佈局醫藥健康產業提供更多的發展機遇,符合公司的戰略規劃和經營計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.